Stage IIIB Cutaneous Melanoma
2 clinical trials · Condition
◉ Watch Stage IIIB Cutaneous Melanoma
| Record | Firm | Date |
|---|---|---|
| Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma (NCT03396952) | University of California, San Francisco | 2018-04-19 |
| Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma (NCT02587650) | University of California, San Francisco | 2015-03-26 |
Track Stage IIIB Cutaneous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.